Litcius/Paper detail

Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAF Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series

Jingran Ji, Chongkai Wang, Marwan Fakih

2021Clinical Colorectal Cancer13 citationsDOI

Topics & Concepts

MedicineCetuximabColorectal cancerOncologyInternal medicineChemotherapyMutationOverall survivalProgression-free survivalCancerGeneGeneticsBiologyColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsGenetic factors in colorectal cancer
Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAF Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series | Litcius